iShares ESG Aware USD Corporate Bond ETF (NASDAQ: SUSC)

Latest News for iShares ESG Aware USD Corporate Bond ETF (NASDAQ:SUSC)

iShares ESG Aware USD Corporate Bond ETF

Long Ideas

Bonds

Specialty ETFs

Trading Ideas

ETFs

SUSC

The Perks Of Going Green In The Corporate Bond Market

News

New ETFs

Markets

SUSB

BlackRock Bolsters Bond ETF Roster With ESG, Smart Beta Funds

ANVS

Annovis Bio Shares Halted On Circuit Breaker To The Downside, Stock Now Down -25.6%

Agilent Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) short percent of float has risen 10.14% since its last report. The company recently reported that it has 3.95 million shares sold short, which is 1.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Agilent Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401922_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Agilent Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Agilent Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Agilent Technologies's peer group average for short interest as a percentage of float is 5.20%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Agilent Technologies?

NNN REIT's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) short percent of float has fallen 9.52% since its last report. The company recently reported that it has 3.54 million shares sold short, which is 2.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.01 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NNN REIT Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401917_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NNN REIT has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing NNN REIT's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NNN REIT's peer group average for short interest as a percentage of float is 5.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(NNN) - Analyzing NNN REIT's Short Interest

Marinus Pharma's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NYSE">MRNS</a>) short percent of float has fallen 3.64% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 6.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.15 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Marinus Pharma Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401912_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marinus Pharma has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Marinus Pharma's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Marinus Pharma's peer group average for short interest as a percentage of float is 3.91%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MRNS

How Is The Market Feeling About Marinus Pharma?

Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) with a Buy and lowers the price target from $65 to $50.

Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on 10x Genomics, Lowers Price Target to $50

TD Securities analyst Greg Barnes maintains Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Hold and raises the price target from $43 to $48.

TD Securities Maintains Hold on Newmont, Raises Price Target to $48

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) with a Hold and lowers the price target from $12 to $3.

TTOO

Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

Decibel Cannabis Company Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DB#TSXV">DB</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTCQB">DBCCF</a>) reported its audited financial results on Monday for the three and twelve month periods ending Dec. 31, 2023.
The Alberta-based company said it saw a record net revenue of CA$116 million ($84.8 million) in 2023, an increase of 46% over 2022.
&#8220;The Company&#8217;s fourth quarter financial results delivered another year of growth across all metrics and I look forward to working with the team to continue to build on this success,&#8221; said Benjamin Sze, Decibel&#8217;s new CEO. Sze was recently <a href="https://www.benzinga.com/markets/cannabis/24/04/38261823/whos-who-in-cannabis-latest-executive-changes-you-should-know-about">appointed to serve</a> as Decibel's CEO, succeeding Paul Wilson. He rejoined the company after previously serving as CEO before resigning in late 2020 for personal reasons.
Decibel kicked off 2024 strong by completing its first export of craft cannabis to Australia in March 2024. This followed receiving its first purchase order for vapes to export to Australia.
See also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36291660/undervalued-cannabis-stock-this-company-could-reach-a-c-1b-valuation-on-the-back-of">Undervalued Cannabis Stock? This Company Could Reach A C$1B Valuation On The Back Of Pre-Roll Sales</a>
The number of companies in the space that are expanding internationally grows by the day, some of them being featured at cannabis events like the recent <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a> in Florida. That event gathered top CEOs, investors and leaders in the cannabis industry. 
<a href="https://cannabismarketspotlight.com/">Benzinga Cannabis Market Spotlight</a> which is slated to take place on June 17 in New Jersey will be another opportunity for those interested to hear insightful business advice from top cannabis experts in the space.
<h3 class="wp-block-heading">FY 2023 Financial Highlights</h3>
<ul>
<li>Net Canadian recreational sales totaled CA$105.8 million, up from CA$68.5 million in the prior year.</li>
<li>International sales totaled CA$3.7 million, up from CA$1.9 million in the prior year.</li>
<li>Retail sales amounted to $6.5 million, down from CA$8.9 million in 2022.</li>
<li>Gross profit before value adjustments totaled CA$51.6 million, up from roughly CA$34 million in the prior year.</li>
<li>Gross margin before value adjustments was 45% compared to 43% in prior year.</li>
<li>Adjusted EBITDA came in positive at approximately CA$26 million, up from a CA$17 million gain in 2022.</li>
<li>Adjusted net income was CA$8 million in 2022, representing an increase of CA$4.9 million over 2022.</li>
<li>Loss and comprehensive loss totaled $CA1.8 million, down from CA$4.4 million in the prior year.</li>
</ul>
<h3 class="wp-block-heading">Q4 2023 Financial Highlights</h3>
<ul>
<li>Net revenue totaled CA$27.7 million, up from CA$25.8 million in the prior year's period.</li>
<li>Net Canadian recreational sales totaled CA$ 24.8 million, compared to CA$ 21.6 in the fourth quarter of 2022.</li>
<li>International sales amounted to CA$1.4 million, down from CA$1.9 million in the prior year's period.</li>
<li>Retail sales totaled CA$1.5 million, down from CA$2.3 million in the fourth quarter of 2022.</li>
<li>Gross profit before value adjustments was CA$12.4 million, compared to CA$11 million in the corresponding period of last year.</li>
<li>Gross margin before value adjustments was 45% compared to 43% in prior year's period.</li>
<li>Adjusted EBITDA came in positive at CA$5.1 million, down from an adjusted EBITDA gain of CA$7 million in the prior year's period.</li>
<li>Loss and comprehensive loss totaled CA$1.2 million, down from CA$3.1 million loss in the fourth quarter of 2022.</li>
</ul>
<h3 class="wp-block-heading">DBCCF Price Action</h3>
Decibel's shares traded 4.78% higher at $0.0965 per share after the market close on Friday.
Now read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37924655/canadian-cannabis-companies-could-see-valuations-soar-by-up-to-300-with-tax-reform-">Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows</a>

Cannabis

Earnings

Events

DBCCF

TSXV:DB

This Undervalued Cannabis Stock Has Another Year Of Growth: Reports Record 2023 Revenue And Adjusted EBITDA

Canaccord Genuity analyst Kyle Mikson maintains Quanterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) with a Buy and lowers the price target from $32 to $25.

QTRX

Canaccord Genuity Maintains Buy on Quanterix, Lowers Price Target to $25

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) with a Buy and lowers the price target from $45 to $30.

Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Annovis Bio Shares Halted On Circuit Breaker To The Downside, Stock Now Down -14.7%

Annovis Bio Shares Resume Trade

Biotech

General

Annovis Bio Shares Halted On Circuit Breaker To The Downside, Stock Now Down -5.22%

WIIM

SIRI

Sirius XM Holdings shares are trading higher after Seaport Global upgraded the stock from Neutral to Buy and announced a $4.3 price target.

Welcome to a new episode of the Benzinga Psychedelics Podcast where we&#8217;re joined by Dr. Matthew X. Lowe, executive director and CSO to Unlimited Sciences, a Colorado-based nonprofit organization conducting and supporting research with psychedelics. Unlimited Sciences recently launched a toll-free "Psychedelic Info Line" to provide pre-psychedelic education and guidance. 
<figure class="wp-block-embed is-type-rich is-provider-spotify wp-block-embed-spotify wp-embed-aspect-21-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe title="Spotify Embed: Increased Destigmatization Of Psychedelics And A Rise In Educational Tools - The World Ahead By Dr. Matthew Lowe" style="border-radius: 12px" width="100%" height="152" frameborder="0" allowfullscreen allow="autoplay; clipboard-write; encrypted-media; fullscreen; picture-in-picture" loading="lazy" src="https://open.spotify.com/embed/episode/5wxnoCqDyHCOqRtOoMjtIo?si=71b4f8fe8e8849c7&#038;utm_source=oembed"></iframe>
</div>
</figure>
Listen to the podcast <a href="https://open.spotify.com/episode/5wxnoCqDyHCOqRtOoMjtIo?si=71b4f8fe8e8849c7">here</a>.
The line is already operational, taking calls worldwide . Even though its main focus is on the preparation side, it also provides tools for integration as requested by users. It welcomes those who are new to psychedelics as well as those with past experience. 
Psychedelics info line navigators are not necessarily experts but rather compassionate individuals who follow detailed scripts based on a variety of topics on psychedelics that were developed by numerous experts.
They are not there to opine or encourage the use of psychedelics nor give medical advice. In fact, the team encourages anyone aiming to begin using these substances to speak with their medical providers, healthcare team or physicians to ascertain whether psychedelics are right for them. 
Scripts and materials are built from a thorough review of published papers and other evidence-based sources on psychedelics, including the "largest naturalistic <a href="https://unlimitedsciences.org/worlds-largest-study-on-naturalistic-psilocybin-use-from-unlimited-sciences-reveals-lasting-therapeutic-benefits/">psilocybin study</a> in the world" (8,000+ individuals enrolled) designed jointly with researchers at Johns Hopkins University and other renowned institutions. 
"We do not want this to be an anecdotal or subjective or opinionated point of view. This is based on evidence that is out there in the field that we can utilize and share, and really translate from an academic context into a context that individuals can understand easily," explains Lowe. He added that the info line aims to provide the necessary information for people to make the decision to take psychedelics an informed one. 
Calls are confidential and don't require personal information. There's also an email service that works for those who want to further protect their identity, providing in-depth answers, educational resources and peer-reviewed evidence to make more informed decisions.
<h3 class="wp-block-heading">Rising Destigmatization To Be Matched With Education And Research Funding </h3>
The needs for the coming world where psychedelics will become increasingly available for use include education for providers as well as users.
"There's a lot of education that needs to be completed on administering psychedelics; and because of the 1971 scheduling, rescheduling of these substances, and the subsequent lack of research that was essentially halted over the following decades, there's not a lot of research still," Lowe says.&nbsp;
Unlimited Sciences' new info line inserts itself in the world of educational and harm reduction tools by providing pre-psychedelic information and education. It's neither a crisis hotline nor a support line for individuals currently taking psychedelics and experiencing challenges -much as <a href="https://www.benzinga.com/markets/cannabis/23/07/33399826/firesides-vision-expanding-support-beyond-harm-reduction-in-psychedelics">Fireside Project</a> or Zendo Project do.
"I think there's an ecosystem developing for both pre-psychedelic and post-psychedelic care that is really going to meld together, and I think it's a fantastic idea that these different resources support each other and provide information for various degrees of the different psychedelic experience," says Lowe.
As much as research is on the rise, there's still a lot to learn about regulations around training, education and administration of psychedelics as well as on the environments that support a successful psychedelic journey.
Lowe says the educational industry will rise to meet this challenge and the sector will grow exponentially. "What we know about psychedelics is changing so rapidly. And I think there is a need for training and certification for these individuals to administer psychedelics."
He also stresses the importance of funding research, which is not keeping up to pace with scientific and societal participation in psychedelics. Research into under-represented communities (<a href="https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1279887/full">see latest published research</a> on the long-term psychological health and wellbeing benefits after ceremonial use of ayahuasca in Middle Eastern and North African immigrants and refugees is particularly lacking.
Listen to the full episode on Spotify or wherever you get your podcasts by searching for &#8220;Benzinga Interviews.&#8221;
Photo courtesy of Unlimited Sciences.

Psychedelics

Education

Psychology

Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences

Intuitive Machines's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NYSE">LUNR</a>) short percent of float has risen 24.74% since its last report. The company recently reported that it has 3.77 million shares sold short, which is 49.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Intuitive Machines Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intuitive Machines has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Intuitive Machines's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Intuitive Machines's peer group average for short interest as a percentage of float is 8.89%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

LUNR

How Is The Market Feeling About Intuitive Machines?

Macro Economic Events

Econ #s

Economics

Dallas Fed Mfg Business Index For April -14.5 Vs -14.4 Prior

Meta Data's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) short percent of float has fallen 40.0% since its last report. The company recently reported that it has 24 thousand shares sold short, which is 0.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Meta Data Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Meta Data has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Meta Data's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Meta Data's peer group average for short interest as a percentage of float is 2.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Meta Data's Recent Short Interest

PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) has outperformed the market over the past 5 years by 7.43% on an annualized basis producing an average annual return of 19.08%. Currently, PACCAR has a market capitalization of $59.74 billion. 
Buying $1000 In PCAR: If an investor had bought $1000 of PCAR stock 5 years ago, it would be worth $2,435.39 today based on a price of $114.00 for PCAR at the time of writing.
<h3>PACCAR's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401018_0_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PCAR

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today

BlackRock's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) short percent of float has risen 3.33% since its last report. The company recently reported that it has 1.82 million shares sold short, which is 1.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BlackRock Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714401013_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BlackRock has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing BlackRock's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BlackRock's peer group average for short interest as a percentage of float is 2.75%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About BlackRock?

iShares ESG Aware USD Corporate Bond ETF declares monthly distribution of $0.0781

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for iShares ESG Aware USD Corporate Bond ETF (NASDAQ:SUSC)

Tuesday, November 26, 2019

Friday, July 14, 2017